CLDX
Celldex Therapeutics, Inc.Healthcare$31.06
▲ Bullish
Mkt Cap: $2.07B|Float: 60.4M|SI: 15.3%|DTC: 9.4
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
4622.0%
52W Range
$14-$35
ATR(14)
$1.84
Exp. Move
±15.4%
P/C Ratio
1.09
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
CLDX Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $0.1M
- Max Pain
- $29.00
- Expected Move
- ±15.4%
- Put/Call OI
- 1.09
- Net Premium
- $0.1M
- Spot Price
- $31.06
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$4.80 | ±15.4% | $26.26 | $35.86 |
| 2026-05-15 | 43 | ±$2.75 | ±8.8% | $28.31 | $33.81 |
| 2026-08-21 | 141 | ±$5.35 | ±17.2% | $25.71 | $36.41 |
| 2026-10-16 | 197 | ±$8.00 | ±25.8% | $23.06 | $39.06 |
| 2026-11-20 | 232 | ±$22.55 | ±72.6% | $8.51 | $53.61 |
| 2026-12-18 | 260 | ±$12.55 | ±40.4% | $18.51 | $43.61 |
Explore CLDX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.